Market Overview:
The global travel vaccines market was worth US$ 5.2 Billion in 2019. Travel vaccines, also known as travel immunizations, are vaccines travelers can get before they visit certain regions across the globe which help protect them from serious diseases. Travel vaccines work by exposing the body to a microorganism or parts of the microorganism of the disease it will protect against. The body responds to the vaccination by making antibodies that will protect it against a situation where there is an exposure to the disease in the future.
The number of international tourist arrivals worldwide increased from 1.0 Billion in 2012 to nearly 1.4 Billion in 2018. A significant number of these travelers journey from developed countries to regions with endemic diseases. As more people travel to countries with endemic diseases, the demand for vaccines will continue to increase. Moreover, regulatory authorities across the globe have also mandated that travelers should be vaccinated before traveling to disease-prone regions. As a result, travel vaccines have now become an essential requirement in an international travelers list. For instance, the Ministry of Health in the Kingdom of Saudi Arabia requires that all travelers arriving for Hajj and Umrah from countries or areas at risk of diseases such as yellow fever, Meningococcal meningitis and Poliomyelitis must present a valid vaccination certificate. Other factors driving the demand for travel vaccines include increasing awareness levels, technological advancements and increasing incidence of life-threatening infectious diseases. Looking forward, IMARC Group expects the global travel vaccines market to exhibit moderate growth during 2020-2025.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global travel vaccines market report, along with forecasts for growth at the global, regional and country-level from 2020-2025. Our report has categorized the market based on region, composition, and disease.
Breakup by Composition:
- Mono Vaccines
- Combination Vaccines
Combination vaccines currently account for the majority of the market share as they are given to travelers in order to protect against multiple diseases.
Breakup by Disease:
- Hepatitis A
- DPT
- Yellow Fever
- Typhoid
- Hepatitis B
- Measles and Mumps
- Rabies
- Meningococcal
- Varicella
- Japanese Encephalitis
- Others
Amongst these, hepatitis A represents the largest disease, dominating the market. It is a viral disease that can be transmitted through direct contact with an infectious person or the consumption of contaminated food and water.
Regional Insights:
- Asia Pacific
- North America
- Europe
- Middle East and Africa
- Latin America
On the geographical front, North America enjoys the leading position in the market. A large number of companies in the region are introducing a superior range of travel vaccines, including a vaccine against varicella.
Competitive Landscape:
The market is concentrated in nature with the presence of a handful of manufacturers who compete in terms of prices and quality. Some of the leading players operating in the market are:
- GlaxoSmithKline Pharmaceuticals Limited
- Sanofi Pasteur
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- ALK-Abelló A/S
- Bavarian Nordic A/S
- Crucell (Subsidiary of Johnson & Johnson)
- CSL Limited
- AstraZeneca PLC
- Altimmune, Inc.
- Abbott Laboratories
- Hoffmann-La Roche, Inc.
Key Questions Answered in This Report:
The global travel vaccines market was worth around US$ 5.2 Billion in 2019.
According to the estimates by IMARC Group, the global travel vaccines market will exhibit moderate growth during the next five years.
Substantial growth in the travel and tourism industry in recent years, along with the growing prevalence of infectious and travel-related diseases, acts as a major factor driving the market.
Regulatory authorities mandating vaccines for travelers coming from disease-prone regions represents one of the major trends in the market.
The coronavirus disease (COVID-19) has negatively impacted the market growth. This can be accredited to lockdowns imposed by governments of several countries that have halted the domestic and international travel services temporarily.
The market has been bifurcated on the basis of the composition into mono and combination vaccines.
Based on the disease, the market has been segregated into hepatitis A, DPT, yellow fever, typhoid, hepatitis B, measles and mumps, rabies, meningococcal, varicella, Japanese encephalitis, and others.
On the geographical front, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
Leading industry players are GlaxoSmithKline Plc, Sanofi Pasteur SA (Sanofi SA), Merck & Co., Inc., Novartis AG, Pfizer Inc., ALK-Abelló A/S, Bavarian Nordic A/S, Johnson & Johnson, CSL Limited, AstraZeneca PLC, Altimmune, Inc., Abbott Laboratories and Hoffmann-La Roche, Inc.
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Travel Vaccines Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Composition
5.5 Market Breakup by Disease
5.6 Market Breakup by Region
5.7 Market Forecast
6 Market Breakup by Composition
6.1 Mono Vaccines
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Combination Vaccines
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Disease
7.1 Hepatitis A
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 DPT
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Yellow Fever
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Typhoid
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Hepatitis B
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Measles and Mumps
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Rabies
7.7.1 Market Trends
7.7.2 Market Forecast
7.8 Meningococcal
7.8.1 Market Trends
7.8.2 Market Forecast
7.9 Varicella
7.9.1 Market Trends
7.9.2 Market Forecast
7.10 Japanese Encephalitis
7.10.1 Market Trends
7.10.2 Market Forecast
7.11 Others
7.11.1 Market Trends
7.12.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Europe
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Asia Pacific
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Middle East and Africa
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Latin America
8.5.1 Market Trends
8.5.2 Market Forecast
9 Global Travel Vaccines Industry: SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Global Travel Vaccines Industry: Value Chain Analysis
10.1 Exploratory Stage
10.2 Preclinical and Clinical Development
10.3 Regulatory Approval
10.4 Manufacturing
10.5 Marketing and Distribution
11 Global Travel Vaccines Industry: Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Global Travel Vaccines Industry: Price Analysis
13 Travel Vaccines Manufacturing Process
13.1 Product Overview
13.2 Raw Material Requirements
13.3 Manufacturing Process
13.4 Key Success and Risk Factors
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 GlaxoSmithKline
14.3.2 Sanofi Pasteur
14.3.3 Merck
14.3.4 Novartis
14.3.5 Pfizer
14.3.6 ALK-Abelló
14.3.7 Bavarian Nordic
14.3.8 Crucell N.V.
14.3.9 CSL Limited
14.3.10 MedImmune, LLC
14.3.11 Altimmune
14.3.12 Abbott Laboratories
14.3.13 F. Hoffman-La Roche Ltd.
List of Figures
Figure 1: Global: Travel Vaccines Market: Major Drivers and Challenges
Figure 2: Global: Travel Vaccines Market: Sales Value (in Billion US$), 2014-2019
Figure 3: Global: Travel Vaccines Market: Breakup by Composition (in %), 2019
Figure 4: Global: Travel Vaccines Market: Breakup by Disease (in %), 2019
Figure 5: Global: Travel Vaccines Market: Breakup by Region (in %), 2019
Figure 6: Global: Travel Vaccines Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 7: Global: Travel Vaccines Industry: SWOT Analysis
Figure 8: Global: Travel Vaccines Industry: Value Chain Analysis
Figure 9: Global: Travel Vaccines Industry: Porter’s Five Forces Analysis
Figure 10: Global: Travel Vaccines (Mono Vaccines) Market: Sales Value (in Million US$), 2014 & 2019
Figure 11: Global: Travel Vaccines (Mono Vaccines) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 12: Global: Travel Vaccines (Combination Vaccines) Market: Sales Value (in Million US$), 2014 & 2019
Figure 13: Global: Travel Vaccines (Combination Vaccines) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 14: Global: Travel Vaccines (Hepatitis A) Market: Sales Value (in Million US$), 2014 & 2019
Figure 15: Global: Travel Vaccines (Hepatitis A) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 16: Global: Travel Vaccines (Hepatitis B) Market: Sales Value (in Million US$), 2014 & 2019
Figure 17: Global: Travel Vaccines (Hepatitis B) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 18: Global: Travel Vaccines (Japanese Encephalitis Vaccines) Market: Sales Value (in Million US$), 2014 & 2019
Figure 19: Global: Travel Vaccines (Japanese Encephalitis Vaccines) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 20: Global: Travel Vaccines (Meningococcal) Market: Sales Value (in Million US$), 2014 & 2019
Figure 21: Global: Travel Vaccines (Meningococcal) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 22: Global: Travel Vaccines (Rabies) Market: Sales Value (in Million US$), 2014 & 2019
Figure 23: Global: Travel Vaccines (Rabies) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 24: Global: Travel Vaccines (Typhoid) Market: Sales Value (in Million US$), 2014 & 2019
Figure 25: Global: Travel Vaccines (Typhoid) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 26: Global: Travel Vaccines (Yellow Fever) Market: Sales Value (in Million US$), 2014 & 2019
Figure 27: Global: Travel Vaccines (Yellow Fever) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 28: Global: Travel Vaccines (Others) Market: Sales Value (in Million US$), 2014 & 2019
Figure 29: Global: Travel Vaccines (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 30: North America: Travel Vaccines Market: Sales Value (in Million US$), 2014 & 2019
Figure 31: North America: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 32: Europe: Travel Vaccines Market: Sales Value (in Million US$), 2014 & 2019
Figure 33: Europe: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 34: Asia Pacific: Travel Vaccines Market: Sales Value (in Million US$), 2014 & 2019
Figure 35: Asia Pacific: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 36: Middle East and Africa: Travel Vaccines Market: Sales Value (in Million US$), 2014 & 2019
Figure 37: Middle East and Africa: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 38: Latin America: Travel Vaccines Market: Sales Value (in Million US$), 2014 & 2019
Figure 39: Latin America: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 40: Travel Vaccines Manufacturing: Process Flow
List of Tables
Table 1: Global: Travel Vaccines Market: Key Industry Highlights, 2019 and 2025
Table 2: Global: Travel Vaccines Market Forecast: Breakup by Composition (in Million US$), 2020-2025
Table 3: Global: Travel Vaccines Market Forecast: Breakup by Disease (in Million US$), 2020-2025
Table 4: Global: Travel Vaccines Market Forecast: Breakup by Region (in Million US$), 2020-2025
Table 5: Travel Vaccines: Raw Material Requirements
Table 6: Global: Travel Vaccines Market Structure
Table 7: Global: Travel Vaccines Market: Key Players